The FDA has approved a combination of Pfizer’s Braftovi and Merck KGaA’s Erbitux for a form of untreated metastatic colorectal cancer, the first targeted drug regimen for this form of the disease.

Mammotion Luba Mini AWD LiDAR: full review of the cordless robotic lawnmower for gardens up to 1500 m². Tri-Fusion LiDAR ...